(Janyce McGregor – CBC News)
Canada’s goal to see its trade agreement with the European Union take flight this summer now appears grounded by a second series of concerns, this time from the pharmaceutical industry.
The concerns, which at first seemed to impose only minor delays, now appear significant enough to require engagement at the highest levels on both sides of the Atlantic.
Justin Trudeau spoke to the president of the European Commission, Jean-Claude Juncker, by telephone Tuesday and “urged proceeding” with a provisional application of the deal as soon as possible “so that its benefits can be realized,” a statement from the Prime Minister’s Office says. Click here to read more.